Ticker Report ResMed Inc. (NYSE:RMD - Get Free Report) CFO Brett Sandercock sold 1,000 shares of ResMed stock in a transaction on Monday, September 9th. The stock was sold at an average price of $246.42, for a...\n more…
Ticker Report ResMed Inc. (NYSE:RMD - Get Free Report) CEO Michael J. Farrell sold 14,683 shares of the company's stock in a transaction that occurred on Monday, September 9th. The stock was sold at an average...\n more…
Ticker Report Candriam S.C.A. increased its holdings in ResMed Inc. (NYSE:RMD - Free Report) by 10.8% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange...\n more…
Globe Newswire Learn more about ResMed's 2030 strategy to accelerate growthJoin in person or via virtual webcast SAN DIEGO, Sept. 10, 2024 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) will host an...\n more…